CPA
LLY icon

Capital Planning Advisors’s Eli Lilly LLY Stock Holding History

Capital Planning Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Buy
3,985
+26
+0.7% +$26.4K 0.53% 34
2025
Q4 		$4.25M Buy
3,959
+215
+6% +$206K 0.57% 36
2025
Q3 		$2.86M Buy
3,744
+759
+25% +$565K 0.39% 52
2025
Q2 		$2.33M Sell
2,985
-48
-2% -$37.3K 0.34% 56
2025
Q1 		$2.5M Buy
3,033
+162
+6% +$135K 0.39% 53
2024
Q4 		$2.22M Buy
2,871
+1,379
+92% +$1.14M 0.34% 58
2024
Q3 		$1.32M Buy
1,492
+329
+28% +$296K 0.2% 65
2024
Q2 		$1.05M Sell
1,163
-194
-14% -$155K 0.18% 72
2024
Q1 		$1.06M Sell
1,357
-4
-0.3% -$2.85K 0.19% 72
2023
Q4 		$793K Sell
1,361
-57
-4% -$33.3K 0.15% 76
2023
Q3 		$762K Hold
1,418
– – 0.16% 74
2023
Q2 		$665K Sell
1,418
-8
-0.6% -$3.35K 0.13% 83
2023
Q1 		$490K Sell
1,426
-10
-0.7% -$3.37K 0.1% 89
2022
Q4 		$525K Sell
1,436
-198
-12% -$70.2K 0.12% 86
2022
Q3 		$528K Buy
1,634
+650
+66% +$206K 0.14% 81
2022
Q2 		$319K Buy
984
+88
+10% +$26.4K 0.08% 102
2022
Q1 		$257K Sell
896
-6
-0.7% -$1.54K 0.06% 138
2021
Q4 		$249K Buy
+902
New +$229K 0.05% 143
2018
Q1 		– Sell
-13,363
Closed -$1.13M – 124
2017
Q4 		$1.13M Buy
13,363
+3,386
+34% +$288K 0.4% 67
2017
Q3 		$853K Buy
9,977
+4,774
+92% +$392K 0.33% 69
2017
Q2 		$428K Buy
+5,203
New +$424K 0.19% 89

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Planning Advisors's LLY Position: Q1 2026 in Review

Capital Planning Advisors increased its Eli Lilly (LLY) stake by 0.66% in Q1 2026, buying an estimated $26.4K and bringing the position to 3,985 shares worth $3.67M. The position accounts for 0.53% of the portfolio, ranked #34.

Capital Planning Advisors first reported a position in LLY in Q2 2017 and has held it in 21 quarters since. The position peaked at $4.25M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Capital Planning Advisors held 3,985 shares of Eli Lilly worth $3.67M as of Q1 2026.
  • Capital Planning Advisors bought 26 Eli Lilly shares in Q1 2026, an estimated $26.4K.
  • Eli Lilly made up 0.53% of Capital Planning Advisors's portfolio in Q1 2026, its #34 holding.
  • Capital Planning Advisors first reported a position in Eli Lilly in Q2 2017 and has held it in 21 quarters since.
  • Capital Planning Advisors's Eli Lilly position peaked at $4.25M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Capital Planning Advisors's 13F filing for Q1 2026, filed 14 May 2026.